Terminal Cancer Syndrome: Myth or Reality?

McCusker J. The terminal period of cancer: definition and descriptive epidemiology. J Chronic Dis 1984; 37(5): 377–385.

Wachtel T , Masterson SA , Reuben D , Goldberg R , Mor V. The end stage cancer patient: terminal common pathway. Hospice J 1989; 4(4): 43–80.

Reuben DB , Mor V , Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 1988; 148: 1586–1591.

Toscani F , on behalf of the Italian Co-operative Research Group on Palliative Medicine. Classification and staging of terminal cancer patients: rationale and objectives of a multicenter cohort prospective study and methods used. Support Care Cancer 1996; 4: 56–60.

Saunders CM . Appropriate treatment, appropriate death. In: Saunders C (ed). The Management of Terminal Disease. London: Arnold, 1978.

National Cancer Institute. PDQ statements (treatment) for health professionals. CancerNet, July 1996; www.cancernet.nci.nih.gov/clinpdg.

Fillenbaum GG , Smyer MA . The development, validity, and reliability of the OARS Multidimensional Functional Assessment Questionnaire. J Gerontol 1981; 36(4): 428–434.

Browne G , Jamieson E , Roberts J , Hay I. Modifications and Scoring of the OARS MFAQ Measure of Functional Capacity: 1991 Canadian Situation. In: System-linked Research Unit on Health and Social Service Service Utilization, Working Paper Series 92-8. Hamilton, Ontario: McMaster University, 1992.

Bruera E , Carraro S , Roca E , Cedaro L , Chacon R. Association between malnutrition and caloric intake, emesis, psychological depression, glucose taste and tumor mass. Cancer Treat Rev 1984; 68: 873–876.

Kamofsky DA , Burchenal JH . The clinical evaluation of chemotherapeutic agents in cancer. In Macleod CM (ed). Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949; pp. 199–205.

Zubrod CG , Sheiderman MA , Frei E , Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis 1960; 11: 7–33.

Kaasa T , Loomis J , Gillis K , Bruera E , Hanson J. The Edmonton Functional Assessment Tool. Preliminary development and evaluation for use in palliative care. J Pain Symptom Manage 1997; 13: 10–19.

Bruera E , Kuehn N , Miller MJ , Selmser P , Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991; 7(2): 6–9.

Aaronson NK , Bullinger M , Ahmedzai S. A modular approach to quality of life assessment in cancer clinical trials. Recent Results Cancer Res 1988; 111: 231–249.

Charlson ME , Ales KA , Pompei P , Mackenzie CR . A new method of classification of prognostic comorbidity for longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–383.

Folstein MF , Folstein SE , McHugh PR . Mini-mental state. J Psychiatr Res 1975; 12: 189–198.

Hollander M , Wolfe DA . Nonparametric Statistical Methods. New York: Wiley, 1973; pp. 115–119.

National Center for Health Statistics, Department of Health and Human Services. Triceps skinfold thickness for adult women and men, United States, 1971–1974. In: Frisancho AR . New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin N 1981; 34(11): 2540–2545.

Alberta Bureau of Statistics. Alberta statistical review. Edmonton, Alberta: Government of Alberta, First quarter, 1991.

Bruera E , Miller L , Mc Callion J , Macmillan K , Krefting L , Hanson J. Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 1992; 7 (4): 192–195.

Massie MJ , Holland J , Glass E. Delirium in terminally ill cancer patients. Am J Psychiatry 1983; 140(8): 1048–1050.

Viganò A , Watanabe S , Bruera E. Anorexia and cachexia in advanced cancer patients. Cancer Surv 1994; 21: 99–115.

Schonwetter RS , Teasdale TA , Storey P , Luchi R. Estimation of survival in advanced cancer patients: an impedance to hospice admissions? Hospice J 1990; 6:4; 65–79.